These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3943010)

  • 21. Porokeratosis in patients with polycythemia rubra vera: a new side effect of hydroxyurea?
    Kanitakis J; Arbona-Vidal E; Faure M
    J Eur Acad Dermatol Venereol; 2012 Aug; 26(8):1040-1. PubMed ID: 21812837
    [No Abstract]   [Full Text] [Related]  

  • 22. Ruxolitinib in patients with polycythemia vera resistant and/or intolerant to hydroxyurea: European observational study.
    Theocharides A; Gisslinger H; De Stefano V; Accurso V; Iurlo A; Devos T; Egyed M; Lippert E; Delgado RG; Cantoni N; Dahm AEA; Sotiropoulos D; Houtsma E; Smyth A; Iqbal A; Di Matteo P; Zuurman M; Te Boekhorst PAW
    Eur J Haematol; 2024 Mar; 112(3):379-391. PubMed ID: 37899734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polycythemia vera and hydroxyurea resistance/intolerance: a monocentric retrospective analysis.
    Demuynck T; Verhoef G; Delforge M; Vandenberghe P; Devos T
    Ann Hematol; 2019 Jun; 98(6):1421-1426. PubMed ID: 30919072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ruxolitinib for the treatment of inadequately controlled polycythemia vera without splenomegaly: 80-week follow-up from the RESPONSE-2 trial.
    Griesshammer M; Saydam G; Palandri F; Benevolo G; Egyed M; Callum J; Devos T; Sivgin S; Guglielmelli P; Bensasson C; Khan M; Ronco JP; Passamonti F
    Ann Hematol; 2018 Sep; 97(9):1591-1600. PubMed ID: 29804268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term management of polycythemia vera with hydroxyurea: a progress report.
    Kaplan ME; Mack K; Goldberg JD; Donovan PB; Berk PD; Wasserman LR
    Semin Hematol; 1986 Jul; 23(3):167-71. PubMed ID: 3749925
    [No Abstract]   [Full Text] [Related]  

  • 26. Hydroxyurea induced oscillations in twelve patients with polycythemia vera.
    Tauscher J; Siegel F; Petrides PE
    Haematologica; 2010 Jul; 95(7):1227-9. PubMed ID: 20220068
    [No Abstract]   [Full Text] [Related]  

  • 27. Real-World Dosing Patterns of Ruxolitinib in Patients With Polycythemia Vera Who Are Resistant to or Intolerant of Hydroxyurea.
    Altomare I; Parasuraman S; Paranagama D; Kish J; Lord K; Yu J; Colucci P
    Clin Lymphoma Myeloma Leuk; 2021 Nov; 21(11):e915-e921. PubMed ID: 34353779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leukemic transformation of polycythemia vera after treatment with hydroxyurea with abnormalities of chromosome 17.
    Tóthová E; Fricová M; Stecová N; Hlebasková M; Kafková A; Raffac S; Guman T; Svorcová E; Nebesnáková E
    Neoplasma; 2001; 48(5):389-92. PubMed ID: 11845984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute myeloid leukemia occurring in a patient with polycythemia vera in treatment with hydroxyurea.
    Cacciola E; Cacciola RR; Guglielmo P; Stagno F; Giustolisi R
    Haematologica; 1999 Aug; 84(8):755-6. PubMed ID: 10457418
    [No Abstract]   [Full Text] [Related]  

  • 30. Hydroxyurea-associated platelet count oscillations in polycythemia vera: a report of four new cases and a review.
    Steensma DP; Harrison CN; Tefferi A
    Leuk Lymphoma; 2001; 42(6):1243-53. PubMed ID: 11911405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. From efficacy to safety: a Polycythemia Vera Study group report on hydroxyurea in patients with polycythemia vera.
    Fruchtman SM; Mack K; Kaplan ME; Peterson P; Berk PD; Wasserman LR
    Semin Hematol; 1997 Jan; 34(1):17-23. PubMed ID: 9025158
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hydroxyurea induced-leg ulcer in polycythemia vera].
    Khaled A; El Guellali N; Aissaoui L; Robbana F; Ezzine N; Fazaa B; Kamoun MR
    Tunis Med; 2011 Mar; 89(3):292-4. PubMed ID: 21387237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydroxyurea-associated acral erythema in a patient with polycythemia vera.
    Butler D; Nambudiri VE; Nandi T
    Am J Hematol; 2014 Sep; 89(9):931-2. PubMed ID: 24585573
    [No Abstract]   [Full Text] [Related]  

  • 34. Management of polycythemia vera with hydroxyurea.
    Tatarsky I; Sharon R
    Semin Hematol; 1997 Jan; 34(1):24-8. PubMed ID: 9025159
    [No Abstract]   [Full Text] [Related]  

  • 35. Reversal of myelofibrosis by hydroxyurea.
    Löfvenberg E; Wahlin A; Roos G; Ost A
    Eur J Haematol; 1990 Jan; 44(1):33-8. PubMed ID: 2307218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia vera.
    Alvarez-Larrán A; Pereira A; Cervantes F; Arellano-Rodrigo E; Hernández-Boluda JC; Ferrer-Marín F; Angona A; Gómez M; Muiña B; Guillén H; Teruel A; Bellosillo B; Burgaleta C; Vicente V; Besses C
    Blood; 2012 Feb; 119(6):1363-9. PubMed ID: 22160617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydroxyurea-induced marked oscillations of platelet counts in patients with polycythemia vera.
    Tefferi A; Elliott MA; Kao PC; Yoon S; El-Hemaidi I; Pearson TC
    Blood; 2000 Aug; 96(4):1582-4. PubMed ID: 10942409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled Disease.
    Geyer H; Scherber R; Kosiorek H; Dueck AC; Kiladjian JJ; Xiao Z; Slot S; Zweegman S; Sackmann F; Fuentes AK; Hernández-Maraver D; Döhner K; Harrison CN; Radia D; Muxi P; Besses C; Cervantes F; Johansson PL; Andreasson B; Rambaldi A; Barbui T; Bonatz K; Reiter A; Boyer F; Etienne G; Ianotto JC; Ranta D; Roy L; Cahn JY; Maldonado N; Barosi G; Ferrari ML; Gale RP; Birgegard G; Xu Z; Zhang Y; Sun X; Xu J; Zhang P; te Boekhorst PA; Commandeur S; Schouten H; Pahl HL; Griesshammer M; Stegelmann F; Lehmann T; Senyak Z; Vannucchi AM; Passamonti F; Samuelsson J; Mesa RA
    J Clin Oncol; 2016 Jan; 34(2):151-9. PubMed ID: 26598745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How safe is hydroxyurea in the treatment of polycythemia vera?
    Haematologica; 1999 Aug; 84(8):673-4. PubMed ID: 10457399
    [No Abstract]   [Full Text] [Related]  

  • 40. Risk of thrombosis according to need of phlebotomies in patients with polycythemia vera treated with hydroxyurea.
    Alvarez-Larrán A; Pérez-Encinas M; Ferrer-Marín F; Hernández-Boluda JC; Ramírez MJ; Martínez-López J; Magro E; Cruz Y; Mata MI; Aragües P; Fox ML; Cuevas B; Montesdeoca S; Hernández-Rivas JA; García-Gutiérrez V; Gómez-Casares MT; Steegmann JL; Durán MA; Gómez M; Kerguelen A; Bárez A; García MC; Boqué C; Raya JM; Martínez C; Albors M; García F; Burgaleta C; Besses C;
    Haematologica; 2017 Jan; 102(1):103-109. PubMed ID: 27686377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.